Reactivaion of immune-related colitis during targeted therapy in a patient with metastatic cutaneous melanoma by E. A. Degtiareva, S. A. Protsenko, E. N. Imyanitov, G. M. Teletaeva, D. Kh. Latipova, A. I. Semenova, A. V. Novik

Subjects: Get full text

Spontaneous haematoma: A unique immune-related adverse event alongside other cutaneous reactions in a patient treated with pembrolizumab for metastatic melanoma by Dalila Malek, Paul Gatt

Subjects: “…Immune related adverse events…”
Get full text

Enteritis of the ileal conduit as an adverse event related to immune checkpoint inhibitor use by Ko Kobayashi, Kohei Hashimoto, Toshiaki Tanaka, Naoya Masumori

Subjects: Get full text

Low triglyceride levels are associated with increased risk of immune-related adverse events in patients receiving immune checkpoint inhibitors by Nora Möhn, Emily Narten, Laura Duzzi, Janin Thomas, Lea Grote-Levi, Gernot Beutel, Tabea Fröhlich, Benjamin-Alexander Bollmann, Thomas Wirth, Imke von Wasielewski, Ralf Gutzmer, Florian Heidel, Frank Pessler, Walter Zobl, Sven Schuchardt, Philipp Ivanyi, Sandra Nay, Thomas Skripuletz

Subjects: Get full text

Association of Sinonasal Symptoms and Disease With Immune Checkpoint Inhibitor Therapy by Jaynelle Gao, Ryan S. Chung, Jason Chwa, Kevin Hur

Subjects: Get full text

Association of vitiligo with immune-checkpoint inhibitor therapy: A systematic review by Lauren Fleshner, MSc, Katie Roster, MD, Lillian Xie, BS, Shari R. Lipner, MD, PhD

Subjects: “…immune-related adverse events…”
Get full text

Recurrent gastric cancer sustaining a partial response after the nivolumab discontinuation because of immune-related adverse events: a case report by Takaaki Arigami, Daisuke Matsushita, Keishi Okubo, Takako Tanaka, Ken Sasaki, Masahiro Noda, Yoshiaki Kita, Shinichiro Mori, Yusuke Tsuruda, Hiroshi Kurahara, Takao Ohtsuka

Subjects: Get full text

Challenges in subtyping disease entities of thyroid dysfunction following combined immune checkpoint inhibitor therapy: a case report by Marco Juul Thomsen, Stine Linding Andersen, Nanna Maria Uldall Torp, Stig Andersen, Allan Carlé

Subjects: Get full text

Cytokine release syndrome after treatment with immune checkpoint inhibitors: an observational cohort study of 2672 patients from Karolinska University Hospital in Sweden by Osama Hamida, Frans Karlsson, Andreas Lundqvist, Marco Gerling, Lisa L. Liu

Subjects: Get full text

Clinical manifestations and risk factors of immune-related thyroid adverse events in patients treated with PD-1 inhibitors: a case-control study by Pengfei Zhao, Jia Li, Lihong Yu, Wenming Ma, Ting Zhao

Subjects: Get full text

Impact of Immunosenescence on Immune‐Related Adverse Events in Elderly Patients With Cancer by Jiayi Gao, Yue Yuan, Xue Wang, Liuer He, Lin Li

Subjects: Get full text

Circulating Plasma Proteins as Biomarkers for Immunotherapy Toxicity: Insights from Proteome-Wide Mendelian Randomization and Bioinformatics Analysis by Liansha Tang, Wenbo He, Handan Hu, Jiyan Liu, Zhike Li

Subjects: Get full text

Preexisting autoantibodies as predictor of immune related adverse events (irAEs) for advanced solid tumors treated with immune checkpoint inhibitors (ICIs) by A Daban, C Gonnin, L Phan, A Saldmann, C Granier, A Lillo-Lelouet, C Le Beller, J Pouchot, l Weiss, E Tartour, E Fabre, J Medioni, S Oudard, YA Vano, MA Dragon-Durey, A. Simonaggio

Subjects: Get full text

Incidence Rates of Cutaneous Immune-Related Adverse Events in Patients with Lung Cancer: A Systematic Review and Meta-Analysis by Zhihui Yang, Yuanyuan Luo, Ruiqi Lu, Xinqi Liu, Hanyu Liu, Suting Liu, Chen Huang, Jinhui Tian, Lili Zhang

Subjects: Get full text

Hepatotoxicity induced by immune checkpoint inhibitors by Flaviu Muresan, Olga Hilda Orasan, Angela Cozma, Madalina Daiana Bancos, Lorena Ciumarnean, Mircea Vasile Milaciu, Tinca Codruta Pocol, Nicoleta Valentina Leach, Teodora Gabriela Alexescu, Ovidiu Vasile Fabian, George Ciulei, Mirela Georgiana Perne

Subjects: Get full text

Immune checkpoint inhibitor-associated autoimmune encephalitis and other neurological immune-mediated adverse events: a pharmacovigilance study using the FAERS and JADER by Xiaomeng Di, Xiaohong Shi, Feng Gai, Jiawei Wang

Subjects: Get full text

Investigating Immune Checkpoint Inhibitor-Induced Pancreatic Injury: When to Discontinue Cancer Therapy by Enrico Celestino Nista, Sara Sofia De Lucia, Sebastiano Archilei, Jacopo Iaccarino, Giulia Piccirilli, Alberto Nicoletti, Angela Saviano, Antonio Gasbarrini, Veronica Ojetti

Subjects: Get full text

Establishment of an animal model of immune‐related adverse events induced by immune checkpoint inhibitors by Yuan Meng, Yingge Lv, Meng Shen, Wenwen Yu, Yumeng Liu, Ting Liu, Gen Liu, Shiya Ma, Zhenzhen Hui, Xiubao Ren, Liang Liu

Subjects: Get full text

Adverse drug reaction assessment of pembrolizumab in cervical cancer treatment: a real-world pharmacovigilance study using the FAERS database by Huiping Zhang, Zhuo Zhou, Juan Wang, Shan Wang, Jie Ren, Ming Zhang, Mingyi Yang

Subjects: Get full text

Real-world single-center data analysis of dual immunotherapy in advanced NSCLC: Efficacy, survival, and adverse events by Tao Luan, Jianqing Hao, Xiaohong Xie, Xinqing Lin, Shuaiying Wang, Baodan Yu, Qingqing Yang, Changchun Wang, Yang Luan, Gang Yang, Hanxiu Lu, Ping Sun, Yunhui Zhang, Nanshan Zhong, Chengzhi Zhou

Subjects: Get full text